Correlation Between Eliem Therapeutics and Anebulo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eliem Therapeutics and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Anebulo Pharmaceuticals.

Diversification Opportunities for Eliem Therapeutics and Anebulo Pharmaceuticals

0.55

Correlation Coefficient

Eliem Therapeutics  Anebulo Pharmaceuticals

Very weak diversification

The 3 months correlation between Eliem and Anebulo is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Anebulo Pharmaceuticals

Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.14 times more return on investment than Anebulo Pharmaceuticals. However, Eliem Therapeutics is 1.14 times more volatile than Anebulo Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest  269.00  in Eliem Therapeutics on August 16, 2024 and sell it today you would earn a total of  111.00  from holding Eliem Therapeutics or generate 41.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Eliem Therapeutics  vs.  Anebulo Pharmaceuticals

Eliem Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Anebulo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Eliem Therapeutics and Anebulo Pharmaceuticals

The main advantage of trading using opposite Eliem Therapeutics and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.

The idea behind Eliem Therapeutics and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.